The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Herpes Marker Testing-Global Market Insights and Sales Trends 2024
Synopsis
Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial diseases such as cold sores, whereas HSV-2 is responsible only for genital herpes. Diagnostic kits available for herpes marker testing include HSV-1 kits, HSV-2 kits and HSV-1/HSV-2 kits.
The global Herpes Marker Testing market size is expected to reach US$ 93 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Herpes Marker Testing in various end use industries. The expanding demands from the Research and Clinic, are propelling Herpes Marker Testing market. HSV-1, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the HSV-2 segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Herpes Marker Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Herpes Marker Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Herpes Marker Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Herpes Marker Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Herpes Marker Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Herpes Marker Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Herpes Marker Testing covered in this report include Abbott Laboratories, Abcam Plc, BioMérieux SA, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel Corporation, Luminex Corporation and Merck KGaA, etc.
The global Herpes Marker Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Abcam Plc
BioMérieux SA
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A.
Quidel Corporation
Luminex Corporation
Merck KGaA
Qiagen N.V.
Norgen Biotek Corp.
Hologic Inc.
Bio Rad Laboratories Inc.
Meridian Bioscience Inc
Teco Diagnostics
Global Herpes Marker Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Herpes Marker Testing market, Segment by Type:
HSV-1
HSV-2
HSV-1/ HSV-2
Global Herpes Marker Testing market, by Application
Research
Clinic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Herpes Marker Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial diseases such as cold sores, whereas HSV-2 is responsible only for genital herpes. Diagnostic kits available for herpes marker testing include HSV-1 kits, HSV-2 kits and HSV-1/HSV-2 kits.
The global Herpes Marker Testing market size is expected to reach US$ 93 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Herpes Marker Testing in various end use industries. The expanding demands from the Research and Clinic, are propelling Herpes Marker Testing market. HSV-1, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the HSV-2 segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Herpes Marker Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Herpes Marker Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Herpes Marker Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Herpes Marker Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Herpes Marker Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Herpes Marker Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Herpes Marker Testing covered in this report include Abbott Laboratories, Abcam Plc, BioMérieux SA, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel Corporation, Luminex Corporation and Merck KGaA, etc.
The global Herpes Marker Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Abcam Plc
BioMérieux SA
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A.
Quidel Corporation
Luminex Corporation
Merck KGaA
Qiagen N.V.
Norgen Biotek Corp.
Hologic Inc.
Bio Rad Laboratories Inc.
Meridian Bioscience Inc
Teco Diagnostics
Global Herpes Marker Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Herpes Marker Testing market, Segment by Type:
HSV-1
HSV-2
HSV-1/ HSV-2
Global Herpes Marker Testing market, by Application
Research
Clinic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Herpes Marker Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Herpes Marker Testing
1.1 Herpes Marker Testing Market Overview
1.1.1 Herpes Marker Testing Product Scope
1.1.2 Herpes Marker Testing Market Status and Outlook
1.2 Global Herpes Marker Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Herpes Marker Testing Market Size by Region (2018-2029)
1.4 Global Herpes Marker Testing Historic Market Size by Region (2018-2023)
1.5 Global Herpes Marker Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Herpes Marker Testing Market Size (2018-2029)
1.6.1 North America Herpes Marker Testing Market Size (2018-2029)
1.6.2 Europe Herpes Marker Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Herpes Marker Testing Market Size (2018-2029)
1.6.4 Latin America Herpes Marker Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Herpes Marker Testing Market Size (2018-2029)
2 Herpes Marker Testing Market by Type
2.1 Introduction
2.1.1 HSV-1
2.1.2 HSV-2
2.1.3 HSV-1/ HSV-2
2.2 Global Herpes Marker Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Herpes Marker Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Herpes Marker Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Herpes Marker Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Herpes Marker Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Herpes Marker Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Herpes Marker Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Herpes Marker Testing Revenue Breakdown by Type (2018-2029)
3 Herpes Marker Testing Market Overview by Application
3.1 Introduction
3.1.1 Research
3.1.2 Clinic
3.2 Global Herpes Marker Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Herpes Marker Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Herpes Marker Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Herpes Marker Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Herpes Marker Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Herpes Marker Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Herpes Marker Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Herpes Marker Testing Revenue Breakdown by Application (2018-2029)
4 Herpes Marker Testing Competition Analysis by Players
4.1 Global Herpes Marker Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Herpes Marker Testing as of 2022)
4.3 Date of Key Players Enter into Herpes Marker Testing Market
4.4 Global Top Players Herpes Marker Testing Headquarters and Area Served
4.5 Key Players Herpes Marker Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Herpes Marker Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Herpes Marker Testing Products, Services and Solutions
5.1.4 Abbott Laboratories Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Abcam Plc
5.2.1 Abcam Plc Profile
5.2.2 Abcam Plc Main Business
5.2.3 Abcam Plc Herpes Marker Testing Products, Services and Solutions
5.2.4 Abcam Plc Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Abcam Plc Recent Developments
5.3 BioMérieux SA
5.3.1 BioMérieux SA Profile
5.3.2 BioMérieux SA Main Business
5.3.3 BioMérieux SA Herpes Marker Testing Products, Services and Solutions
5.3.4 BioMérieux SA Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific, Inc. Recent Developments
5.4 Thermo Fisher Scientific, Inc.
5.4.1 Thermo Fisher Scientific, Inc. Profile
5.4.2 Thermo Fisher Scientific, Inc. Main Business
5.4.3 Thermo Fisher Scientific, Inc. Herpes Marker Testing Products, Services and Solutions
5.4.4 Thermo Fisher Scientific, Inc. Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific, Inc. Recent Developments
5.5 F. Hoffmann-La Roche Ltd.
5.5.1 F. Hoffmann-La Roche Ltd. Profile
5.5.2 F. Hoffmann-La Roche Ltd. Main Business
5.5.3 F. Hoffmann-La Roche Ltd. Herpes Marker Testing Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche Ltd. Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
5.6 DiaSorin S.p.A.
5.6.1 DiaSorin S.p.A. Profile
5.6.2 DiaSorin S.p.A. Main Business
5.6.3 DiaSorin S.p.A. Herpes Marker Testing Products, Services and Solutions
5.6.4 DiaSorin S.p.A. Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.6.5 DiaSorin S.p.A. Recent Developments
5.7 Quidel Corporation
5.7.1 Quidel Corporation Profile
5.7.2 Quidel Corporation Main Business
5.7.3 Quidel Corporation Herpes Marker Testing Products, Services and Solutions
5.7.4 Quidel Corporation Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Quidel Corporation Recent Developments
5.8 Luminex Corporation
5.8.1 Luminex Corporation Profile
5.8.2 Luminex Corporation Main Business
5.8.3 Luminex Corporation Herpes Marker Testing Products, Services and Solutions
5.8.4 Luminex Corporation Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Luminex Corporation Recent Developments
5.9 Merck KGaA
5.9.1 Merck KGaA Profile
5.9.2 Merck KGaA Main Business
5.9.3 Merck KGaA Herpes Marker Testing Products, Services and Solutions
5.9.4 Merck KGaA Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Merck KGaA Recent Developments
5.10 Qiagen N.V.
5.10.1 Qiagen N.V. Profile
5.10.2 Qiagen N.V. Main Business
5.10.3 Qiagen N.V. Herpes Marker Testing Products, Services and Solutions
5.10.4 Qiagen N.V. Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Qiagen N.V. Recent Developments
5.11 Norgen Biotek Corp.
5.11.1 Norgen Biotek Corp. Profile
5.11.2 Norgen Biotek Corp. Main Business
5.11.3 Norgen Biotek Corp. Herpes Marker Testing Products, Services and Solutions
5.11.4 Norgen Biotek Corp. Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Norgen Biotek Corp. Recent Developments
5.12 Hologic Inc.
5.12.1 Hologic Inc. Profile
5.12.2 Hologic Inc. Main Business
5.12.3 Hologic Inc. Herpes Marker Testing Products, Services and Solutions
5.12.4 Hologic Inc. Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Hologic Inc. Recent Developments
5.13 Bio Rad Laboratories Inc.
5.13.1 Bio Rad Laboratories Inc. Profile
5.13.2 Bio Rad Laboratories Inc. Main Business
5.13.3 Bio Rad Laboratories Inc. Herpes Marker Testing Products, Services and Solutions
5.13.4 Bio Rad Laboratories Inc. Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Bio Rad Laboratories Inc. Recent Developments
5.14 Meridian Bioscience Inc
5.14.1 Meridian Bioscience Inc Profile
5.14.2 Meridian Bioscience Inc Main Business
5.14.3 Meridian Bioscience Inc Herpes Marker Testing Products, Services and Solutions
5.14.4 Meridian Bioscience Inc Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Meridian Bioscience Inc Recent Developments
5.15 Teco Diagnostics
5.15.1 Teco Diagnostics Profile
5.15.2 Teco Diagnostics Main Business
5.15.3 Teco Diagnostics Herpes Marker Testing Products, Services and Solutions
5.15.4 Teco Diagnostics Herpes Marker Testing Revenue (US$ Million) & (2018-2023)
5.15.5 Teco Diagnostics Recent Developments
6 North America
6.1 North America Herpes Marker Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Herpes Marker Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Herpes Marker Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Herpes Marker Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Herpes Marker Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Herpes Marker Testing Market Dynamics
11.1 Herpes Marker Testing Industry Trends
11.2 Herpes Marker Testing Market Drivers
11.3 Herpes Marker Testing Market Challenges
11.4 Herpes Marker Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
